Advances in ATTR-CM: Evolving Diagnostics and Therapeutics

Guest: Kevin Alexander In the past decade, significant strides have been made in diagnosing and treating patients with transthyretin amyloid cardiomyopathy (ATTR-CM). Increased disease awareness, non-invasive diagnostic tools like scintigraphy, and AI-assisted screening have led to earlier detection and improved outcomes. Learn more with Dr. Kevin Alexander, an Assistant Professor of Cardiovascular Medicine at the Stanford University School of Medicine.